x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

James Riddle, MCSE, CIP, CPIA, CRQM

SVP, Global Review Services, Advarra

With 25+ years’ experience providing support to the clinical research community, James Riddle helps sponsors, CROs, and research sites advance clinical research with a mission to improve human health. His expertise includes developing and operationalizing processes for maximum efficiency, client satisfaction, and participant protection; development and implementation of technology solutions; and efficient, compliant operation of large clinical research review programs. Prior to Advarra, Riddle held leadership roles at two major central IRBs and served as a senior leader within the research oversight office at the Fred Hutchinson Cancer Research Center. He is also a member of CTTI, NWABR, SASI, and PRIM&R.

James Riddle

Latest Posts by James

 
Blog

DMC vs EAC: What’s the Difference?

This blog outlines the requirements for each committee, what it does, and the critical roles each plays in keeping research participants safe.

Read Now
5 min. read
Read more
 
White Paper

Planned Emergency Research and Exception from Informed Consent

This white paper outlines considerations for those involved in planning, designing, conducting or reviewing EFIC studies

Read Now
Read more
 
Podcast

Trend Forecasting: What Does 2022 Have In Store for Clinical Research?

What will be the 2022 trends in clinical research? In this episode, we forecast what is coming up for clinical trials.

Listen Now
Read more
 
Podcast

James Riddle and Willie Muehlhausen Discuss Digital Technology and Virtual Data Collection in Clinical Research

In this episode, we discuss the growth of decentralized clinical trial technology and how IRBs evolved to account for technology advancements.

Listen Now
Read more
 
Webinar

Integrating Expert Opinions: Why Your Clinical Trial Needs an EAC

In this webinar, we discuss the role of independent endpoint adjudication committees, from charter creation through end of study closeout.

Watch Now
Read more
 
Blog

Reflections from Cell and Gene Meeting on the Mesa 2021

This blog recounts the 2021 Cell and Gene Meeting on the Mesa conference, including details on cell and gene therapy's growth and trajectory.

Read Now
4 min. read
Read more
 
Podcast

James Riddle and Barbara Schneider Delve into the Different Players Involved in Reviewing Clinical Research

In this podcast episode, we discuss the different clinical research oversight committees and functions to ensure the safety of participants.

Listen Now
Read more
 
Webinar

Do You Have Appropriate Oversight? Understanding the Role of DSMBs

Take a look at the role and function of independent DMCs from charter creation through interim data analysis to prepare your next trial.

Watch Now
Read more
 
Webinar

Is Your Site Ready to Conduct Gene Therapy Research?

June 15, 2021

Watch Now
Read more
 
Blog

Cell & Gene Therapy vs Drug Research: What’s the Difference?

In the past year, cell and gene therapy research has exploded. Understand how this field differs from traditional drug development.

Read Now
3 min. read
Read more
 
Podcast

James Riddle and Luke Gelinas Explore Digital Health and Regulation

This podcast covers an array of topics as they explore how COVID has been a catalyst for change, what digital health means for running clinical trials, and how sponsors, CROs, sites, and IRBs can consider when reviewing new digital technologies as a result of COVID.

Listen Now
Read more
 
Blog

How Sites Can Win in the New Age of Genetically Engineered Treatments

The accelerating gene therapy market is expected to grow 16.6 percent by 2027. As gene therapies enter the pipeline, how can sites prepare themselves to take advantage of the rush?

Read Now
6 min. read
Read more